Guideline Central Blog

Guidelines Side-By-Side COPD

Comparing the Management of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations Guidelines – Guidelines Side-By-Side

Posted on

The chronic and progressive nature of chronic obstructive pulmonary disease (COPD) is frequently marked by exacerbations, which are clinically defined as episodes of worsening respiratory symptoms such as dyspnea, cough, increased sputum production, and heightened sputum purulence. These exacerbations not only diminish the quality of life for individuals with COPD but also hasten disease advancement, […]

Posted in Alerts, Guidelines, Miscellaneous, Uncategorized | Tagged , ,
ASH 2024 Conference Preview - Bleeding & Clotting Disorders

2024 ASH Annual Meeting and Exposition – Conference Preview on Bleeding & Clotting Disorders

Posted on

The 66th ASH Annual Meeting and Exposition is set to take place from December 7-10, 2024, in San Diego, California, as well as online. This event stands as the premier hematology gathering of the year, attracting over 30,000 health professionals, clinicians, researchers, educators, and other industry experts. Attendees can expect a multitude of sessions, thousands […]

Posted in Miscellaneous, News, Uncategorized | Tagged ,
Guideline Spotlight - Adult Vaccination Schedule

CDC Adult Vaccination Schedule (2025) – Guidelines Spotlight 

Posted on

Welcome to the latest edition of our Guideline Spotlight, where we delve into the significant changes and key takeaways from the Centers for Disease Control and Prevention’s (CDC) Adult Immunization Schedule for Ages 19 Years or Older, United States, 2025. This schedule serves as a valuable tool for healthcare providers to determine the recommended vaccines […]

Posted in Guidelines, Miscellaneous, News, Uncategorized | Tagged
Guideline Spotlight - Childhood & Adolescents Vaccination Schedule

CDC Childhood and Adolescent Vaccination Schedule (2025) – Guidelines Spotlight 

Posted on

In this edition of our Guideline Spotlight, where we take a look into the significant changes and key takeaways from the Centers for Disease Control and Prevention’s (CDC) Recommended Childhood and Adolescent Immunization Schedule: United States, 2025. This schedule serves as a valuable tool for healthcare providers to determine the recommended vaccines for individuals within […]

Posted in Guidelines, Miscellaneous, News, Uncategorized | Tagged
Guidelines Side-By-Side Diabetic Retinopathy

Comparing Diabetic Retinopathy Guidelines – Guidelines Side-By-Side

Posted on

Diabetic retinopathy, the most prevalent microvascular complication of both type 1 and type 2 diabetes, stands as a primary contributor to new cases of vision impairment among individuals aged 20 to 74 in the United States. This condition serves as the ocular manifestation of end-organ damage in diabetes mellitus. Factors that heighten the risk of […]

Posted in Alerts, Guidelines, Miscellaneous, Uncategorized | Tagged , ,
ACR 2024 Recap

ACR Convergence 2024 – Conference Recap on Gout

Posted on

The American College of Rheumatology’s annual meeting, ACR Convergence 2024, was held from November 14 to 19 at the Walter E. Washington Convention Center in Washington, D.C. This prestigious event brought together leading experts in the field to exchange the latest advancements in rheumatology. At ACR Convergence 2024, several significant abstracts were presented focusing on […]

Posted in Miscellaneous, News, Uncategorized | Tagged ,
BAD Int'l Guidelines

British Association of Dermatologists (BAD) – Guidelines International Series

Posted on

In this installment of our Guidelines International Series, we delve into the rich history of the British Association of Dermatologists (BAD), a venerable society established in 1919 by Sir Archibald Gray, then Editor of the British Journal of Dermatology. The BAD’s guiding principle, ‘healthy skin for all’, remains the cornerstone of their mission, although it […]

Posted in Miscellaneous, News, Uncategorized | Tagged ,
Guideline Timeline - Ulcerative Colitis Management

Ulcerative Colitis Management – Guidelines Timeline

Posted on

Ulcerative colitis (UC) impacts nearly 2 million individuals in the United States. This chronic inflammatory bowel disease typically emerges in early adulthood and follows a pattern of relapsing and remitting symptoms. Unfortunately, up to 20% of patients may eventually require colectomy, and 33% may need hospitalization for disease management. Effectively controlling inflammatory activity is essential […]

Posted in Miscellaneous, News, Uncategorized | Tagged
AHA 2024 Conference Recap - Hypertension

AHA24 – Conference Recap on Hypertension

Posted on

The American Heart Association’s (AHA) annual meeting, AHA24, was held from November 16-18, 2024, at the McCormick Place Convention Center in Chicago, Illinois. This prestigious event serves as the premier global platform for showcasing the latest advancements in cardiovascular science and medicine, providing attendees with the opportunity to engage with cutting-edge research and practice-changing educational […]

Posted in Miscellaneous, News, Uncategorized | Tagged ,
Guidelines+ Trials Spotlight - Kisqali HR+HER2 Early Breast Cancer Results (NATALEE)

Kisqali HR+/HER2- Early Breast Cancer Results (NATALEE) – Guidelines+ Trials Spotlight

Posted on

On September 17, 2024, the US Food and Drug Administration (FDA) granted approval for Novartis’s Kisqali® (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of individuals with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early cancer (EBC) at high risk of recurrence, including those with node-negative […]

Posted in Alerts, Miscellaneous, News | Tagged ,

ASCO’s Thyroid Cancer Guideline is Now Open for Public Comment

Posted on

The American Society of Clinical Oncology (ASCO) has announced that the following guideline, “Systemic Treatment of Thyroid Cancer” is now open for public comment.  This latest guideline incorporates new evidence to ensure the most current recommendations are provided. As part of ASCO’s development process, they invite reviews and feedback for a 2-to-3-week period. Interested parties […]

Posted in Guidelines, Miscellaneous, News, Uncategorized | Tagged ,
Guidelines + Trials Rundown Actinic Keratosis

Actinic Keratosis in Adults – Guidelines+ Trials Rundown

Posted on

Today, we will be looking into the latest research and clinical trials focused on actinic keratosis in adults. The following list has been carefully curated by evaluating the ongoing phase 3 trials for actinic keratosis, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. This […]

Posted in Alerts, Miscellaneous, Uncategorized | Tagged
Guidelines Rundown - COPD

Chronic Obstructive Pulmonary Disease (COPD) – Guidelines Rundown (COPD Awareness Month)

Posted on

Our Guidelines Rundown Series persists with a fresh article delving into the topic of chronic obstructive pulmonary disease (COPD) in recognition of COPD Awareness Month 2024. To aid in clinical decision-making, numerous societies have published extensive guidelines addressing different facets of COPD, such as nutrition management, COPD exacerbations, home oxygen therapy, and more. This article […]

Posted in Miscellaneous, News, Uncategorized | Tagged ,
Guidelines Rundown - Non-Cancer Bladder Health

Non-Cancer Bladder Health – Guidelines Rundown (Bladder Health Awareness Month)

Posted on

The Urology Care Foundation, the official Foundation of the American Urological Association (AUA), is utilizing the month of November to address the stigma surrounding bladder health issues. Our goal is to provide resources that raise awareness and facilitate conversations between patients and their healthcare providers. In support of Bladder Health Awareness Month 2024, this edition […]

Posted in Miscellaneous, News, Uncategorized | Tagged ,
What's Changed Epilepsy

Epilepsy – What’s Changed

Posted on

Each November, we commemorate National Epilepsy Awareness Month (NEAM), focusing on educating the public about epilepsy symptoms and supporting research efforts. In honor of NEAM, today’s article will focus on epilepsy. According to the Centers for Disease Control (CDC), between 2021 and 2022, approximately 2.9 million adults aged 18 and older reported experiencing active epilepsy, […]

Posted in Miscellaneous, News, Uncategorized | Tagged
Guideline Timeline - Stage IV NSCLC Without Driver Alterations

Stage IV NSCLC Without Driver Alterations – Guidelines Timeline

Posted on

In the most recent edition of our Guidelines Timeline Series, we explore the American Society of Clinical Oncology’s (ASCO) guideline on Stage IV Non-Small Cell Lung Cancer without Driver Alterations, which was published on February 28, 2024. This guideline was introduced by ASCO as a living document, that is continuously updated to reflect the latest […]

Posted in Miscellaneous, News, Uncategorized | Tagged
Guidelines Side-By-Side Prostate Cancer

Comparing Prostate Cancer Guidelines – Guidelines Side-By-Side

Posted on

Prostate cancer continues to be the most prevalent non-cutaneous cancer among men in the United States (US), with an estimated 268,490 new cases and 34,500 deaths projected for 2022. Given that the majority of newly diagnosed prostate cancer patients present with localized disease, it is crucial to provide evidence-based guideline statements to guide clinical decision-making […]

Posted in Alerts, Guidelines, Miscellaneous, Uncategorized | Tagged , ,
Guidelines Spotlight Gastropancreatic Neuroendocrine Tumors

Gastroenteropancreatic Neuroendocrine Tumors – Guidelines Spotlight

Posted on

In this edition of our Guideline Spotlight, we will explore the key insights and takeaways from the American Society of Clinical Oncology’s (ASCO) comprehensive guideline, Systemic Therapy for Tumor Control in Metastatic Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). This guideline offers evidence-based recommendations for the treatment of advanced or metastatic GEP-NETs, a rare group of tumors […]

Posted in Guidelines, Miscellaneous, News, Uncategorized | Tagged
Guidelines Rundown - Epilepsy

Epilepsy – Guidelines Rundown (Epilepsy Awareness Month)

Posted on

November is National Epilepsy Awareness Month (NEAM), a time dedicated to raising awareness about epilepsy and supporting research efforts. In honor of NEAM, our Guidelines Rundown Series presents a new article focusing on epilepsy. Epilepsy is a well-known condition that affects 1% of adults in the United States. According to the Centers for Disease Control […]

Posted in Miscellaneous, News, Uncategorized | Tagged ,

Fluticasone Furoate, Umeclidinium, & Vilanterol Inhalation Powder (Trelegy Ellipta/GSK) – Guidelines+ Monographs

Posted on

Welcome to the latest edition of our Guidelines+ Monographs Series. In this installment, we will delve into the medication fluticasone furoate, umeclidinium, and vilanterol, marketed under the brand name Trelegy Ellipta by GlaxoSmithKline. Trelegy Ellipta is a combination of fluticasone furoate, an inhaled corticosteroid (ICS); umeclidinium, an anticholinergic; and vilanterol, a long-acting beta2-adrenergic agonist (LABA) indicated […]

Posted in Miscellaneous, News, Uncategorized | Tagged , ,
Guidelines Rundown - Premature Birth

Premature Birth – Guidelines Rundown (National Prematurity Awareness Month)

Posted on

November is recognized as National Prematurity Awareness Month, with World Prematurity Day being observed annually on November 17th to raise awareness about preterm birth. The incidence of preterm birth is increasing globally, with an estimated 15 million infants born preterm each year (more than 3 weeks early), as reported by the World Health Organization (WHO). […]

Posted in Miscellaneous, News, Uncategorized | Tagged ,

SCAI’s Guideline for the Management of Chronic Venous Disease is Now Open for Public Comment

Posted on

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced that the latest draft of the Clinical Practice Guidelines for the Management of Chronic Venous Disease is now available for public comment.  Chronic Venous Disease (CVD) is a condition that is often overlooked by healthcare providers, yet it can have a significant impact on patients’ […]

Posted in Guidelines, Miscellaneous, News, Uncategorized | Tagged ,
What's Changed Dravet Syndrome

Dravet Syndrome Guidelines – What’s Changed

Posted on

Dravet syndrome is a rare form of epilepsy that typically manifests in infancy or early childhood. According to the National Institutes of Health (NIH), initial symptoms often present as either focal or generalized convulsive seizures that begin before the age of 15 months, with many cases occurring before the age of one. These initial seizures […]

Posted in Miscellaneous, News, Uncategorized | Tagged
Canadian Coalition for Seniors’ Mental Health (CCSMH) Int'l Guidelines

Canadian Coalition for Seniors’ Mental Health (CCSMH) – Guidelines International Series

Posted on

In this installment of our Guidelines International Series, we will delve into the guidelines established by the Canadian Coalition for Seniors’ Mental Health (CCSMH). The CCSMH is committed to enhancing the quality of care and support for older adults throughout Canada. Their primary focus is on bridging gaps in knowledge and practice to ensure that […]

Posted in Miscellaneous, News, Uncategorized | Tagged ,
Guidelines Spotlight Non-Muscle Invasive Bladder Cancer

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer – Guidelines Spotlight (Bladder Health Awareness Month)

Posted on

In the United States, it is estimated that there will be 83,190 new cases of bladder cancer and 16,840 bladder cancer-related deaths in 2024. Approximately 25% of newly diagnosed patients are found to have muscle-invasive disease, a statistic that has remained relatively unchanged over the past decade according to data from the Surveillance, Epidemiology, and […]

Posted in Guidelines, Miscellaneous, News, Uncategorized | Tagged
Categories
Tags

2022 Recap Abstracts ACC/AHA AGA AHRQ American Gastroenterological Association Aortic Disease Approved Drugs Breast Cancer Breast Cancer Awareness Month Cardiology Guidelines Clinical Guidelines Clinical Practice Guidelines Clinical Trials Colorectal Cancer Colorectal Cancer Awareness Month Colorectal Cancer Screening Guidelines Diabetes FDA & Drugs FDA Approvals FDA Approved Guideline Adherence Guideline Alerts Guideline Implementation Strategy Guidelines Guidelines Library Guideline Summaries Healthcare IBS Guidelines International Guidelines Irritable Bowel Syndrome (IBS) Lung Cancer Medical Conference medical journals Medications Monographs Monthly Alerts New April Guidelines News NGC Publications PubMed Research Tuberculosis Guidelines USPSTF